Pharmafile Logo
Pharmafocus logo
Advanced Search
EMA image

EMA: no cancer risk from GLP-1s

July 29, 2013
Research and Development, Sales and Marketing Cancer, EMA, GLP-1s

One of the European Medicines Agency’s key advisory groups has decided that concerns over an increased cancer risk with some …

News
Forxiga image

AZ and BMS go for second Forxiga submission

July 29, 2013
Sales and Marketing AZ, BMS, FDA, Forxiga

AstraZeneca and partner Bristol-Myers Squibb have resubmitted their diabetes drug Forxiga to the FDA 18 months after it was rejected …

News

Boehringer nears European approval for first cancer drug

July 29, 2013
Sales and Marketing Boehringer, Cancer, FDA, afatinib

Boehringer’s first cancer drug is just months away from being approved in Europe after a committee for the EMA gave …

News
tim_roberts

PCI hires associate director of Clinical Trials

July 29, 2013
Manufacturing and Production, Research and Development, Sales and Marketing

Pharma packaging and clinical trials services firm PCI has appointed Tim Roberts as an associate director of Clinical Trials.The changes …

Appointment

Contract research news in brief

July 26, 2013
Research and Development Ascendancy Healthcare, CRO Solutions, Clinical Research Advantage, ResearchDx, SPS Pharma Services, VxP Pharma

Quintiles wins multi-year contract in China, CRO Solutions sets up niche subsidiary and CRA buys CNS unit, plus relocations for …

News
dementia image

Dementia project pays out £50 million

July 26, 2013
Medical Communications, Sales and Marketing Jeremy Hunt, dementia

Over a hundred hospitals and care homes across England have been awarded a share of a £50million fund to help …

News
BMS image

Sharp fall in sales for Bristol-Myers Squibb

July 26, 2013
Sales and Marketing Avapro, BMS, Plavix, Q2

Bristol-Myers Squibb has seen a fall in sales over the past three months as it struggles with major patent losses. …

News
Lilly image

Lilly beats estimates with solid Q2 performance

July 26, 2013
Sales and Marketing Q2, cymbalta, lilly, zyprexa

Lilly posted a healthy set of financials at the end of July as the company looks to keep its growth …

News
Lonza image

Teva and Lonza abandon biosimilars joint venture

July 26, 2013
Manufacturing and Production, Research and Development CMO, Levin, Lonza, Teva, biosimilars

Escalating costs have led Teva and contract manufacturing organisation (CMO) Lonza to abandon a joint venture set up in 2009 …

News
finbarr-martin-bw

Two non-executive directors join NICE Board

July 26, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DoH, NICE, finbarr martin, mumford

The Department of Health has announced that two new non-executive directors will join the National Institute for Health and Care …

Appointment
Roche image

Strong growth for Roche in latest results

July 25, 2013
Sales and Marketing Alexion, Q2, Rituxan, Roche

Roche has seen strong sales growth in the past six months as it lines up new products to replace its …

News

UK rejects meningitis B vaccine Bexsero

July 25, 2013
Sales and Marketing Bexsero, Novartis, Vaccine, meningitis b

The UK government’s department for vaccinations has stunned observers by failing to back the world’s only vaccine for meningitis B. …

News
GSK image

Actions in China ‘shameful’ says GSK boss

July 25, 2013
Medical Communications, Sales and Marketing China, GSK, Witty, bribery

GlaxoSmithKline has admitted that allegations of corruption at its China business are ‘shameful’ and will seek out its cause. Speaking …

News
andrew_monaghan_chiltern__jul_2013

Chiltern hires Andrew Monaghan as director

July 25, 2013
Manufacturing and Production, Research and Development, Sales and Marketing CRO, chiltern, monaghan

Contract research organisation Chiltern has appointed Andrew Monaghan as its director of Global Pharmacovigilance. Monaghan has more than 30 years’ …

Appointment
Benlysta image

Benlysta once again rejected by NICE

July 25, 2013
Sales and Marketing Benlysta, GSK, NHS, NICE

NICE has opened a second public consultation for GSK’s lupus drug Benlysta after the Institute has again rejected the medicine …

News
AMRI image

AMRI says troubled Burlington plant back on track

July 24, 2013
Manufacturing and Production AMRI, FDA, GMP

It looks like contract research and manufacturing organisation AMRI can put the quality problems at its facility in Burlington behind …

News
gsk image

GSK sales up – impact of China allegations to follow

July 24, 2013
Sales and Marketing GSK, Q2, Seretide, Seroxat, Witty, bribery, transparency

GlaxoSmithKline has reported a modest rise in sales but the fallout from China’s bribery probe dominates the firm’s release of …

News
lilly image

Transition Therapeutics buys into Lilly bone drug

July 24, 2013
Research and Development, Sales and Marketing Transition, bone, lilly

Transition Therapeutics has bought Lilly’s early-stage osteoarthritis drug TT-601 that is designed to help patients with chronic bone pain. Transition …

News
Roche image

New Roche leukaemia drug beats rival

July 24, 2013
Research and Development, Sales and Marketing Rituxan, Roche, leukaemia, obinutuzumab

Roche’s next generation leukaemia drug obinutuzumab has beaten the firm’s ageing blood cancer medicine Rituxan in a late-stage trial. The …

News
richard bergstrom image

Pharma groups want limited data release

July 24, 2013
Research and Development, Sales and Marketing EFPIA, Goldacre, PhRMA, all trials, transparency

The two main US and European pharma lobby groups have released a joint statement saying they welcome independent reviews of …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026